Tuesday 26 January

12.00 – 13.30 Registration & Buffet Lunch

13.30 – 14.00 STOP Cervical Cancer Petition Presentation

14.00 – 14.40 CCSM Session 1, Opening Remarks & Keynote Speeches

14.00 – 14.10 Welcoming Remarks: Co-Chair of the PCCP14.10 – 14.25 Opening Address: Ms Androulla Vassiliou (TBA), EU Commissioner for Health14.25 – 14.40 Keynote Speech: Cervical Cancer Survivor

14.40 – 16.00 CCSM Session 2, Cervical Cancer Screening in Europe

Chair: National PCCP MemberPresentation 1: The implementation of organised cervical cancer screeningprogrammes in the EU to the end of 2009Presentation 2: The implementation of organised cervical cancer screeningprogrammes in non-EU European countries to the end of 2009Presentation 3: Implementation case study – The Irish national organisedcervical cancer screening programmeOpen discussion

16.00 – 16.30 Coffee

16.30 – 18.30 CCSM Session 3, New Technologies for Cervical Cancer Screening

Chair: National PCCP MemberPresentation 1: Liquid-based cytology and computer assisted screeningPresentation 2: HPV testing for primary screeningPresentation 3: Assessing the costs and benefits of new technologies withinnational cervical cancer prevention programmesOpen discussion

18.30 – 19.30 Cocktail Reception EP Rm. TBA

19.30 – 22.30 Conference Dinner, EP Members’ Salons

Wednesday 27 January

08.00 – 09.00 Registration & Coffee

09.00 – 09.10 CCSM Session 4, Opening Remarks

09.00 – 09.10 Welcoming Remarks: Co-Chair of the PCCP

09.10 – 10.30 CCSM Session 5, HPV Vaccination in Europe

Chair: National PCCP MemberPresentation 1: The implementation of HPV vaccination programmes in the EUto the end of 2009Presentation 2: The implementation of HPV vaccination programmes in non-EUEuropean countries to the end of 2009Presentation 3: Implementation case study: School-based HPV VaccinationProgrammes – the Scottish ExamplePresentation 4: Implementation case study: Factors Required for EffectivePopulation Coverage in Non-School-Based Programmes (Country/Region TBA)Presentation 5: Implementation case study: Factors Required for EffectivePopulation Coverage in Non-School-Based Programmes (Country/Region TBA)Open discussion

10.40 – 11.10 Coffee

11.10 – 12.10 CCSM Session 6, HPV Vaccination in Europe

Chair: National PCCP MemberPresentation 1: The Latest Data from the Clinical TrialsPresentation 2: A Review of HPV Vaccination SafetyPresentation 3: HPV Vaccination of Women Aged 18-26Open discussion

12.10 – 12.30 The Way Forward

12.10 – 12.30 Maximising Cervical Cancer Reductions: The Effective Integration of Screeningwith HPV Vaccination

12.30 – 13.00 Next Steps and Closing Remarks

12.30 – 12.40 Review of the Key Points of the Congress: Co-Chair of the PCCP12.40 – 12.55 Closing Speech12.55 – 13.00 Closing Remarks: Co-Chair of the PCCP

13.00 – 14.00 Buffet Lunch

14.00 Departure for Airport